>
  1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Joy Hu
Joy Hu
Articles (406) 

Weekly CEO Buys Highlight

Details the CEO buys this past week for the following companies: Summit Therapeutics, American Assets Trust, Dun & Bradstreet Holdings, OPKO Health and ViewRay

According to GuruFocus Insider Data, these were the largest CEO buys during the past week.

Summit Therapeutics

Summit Therapeutics Inc. (NASDAQ:SMMT) CEO and 10% Owner Robert W. Duggan bought 14,071,856 shares on Nov. 6 at a price of $3.34. The price of the stock has increased by 45.21% since then.

8e8065cd9d7a220fff837781a4e4867b.png

Summit Therapeutics is a biopharmaceutical company. It is involved in the business of discovery, development and commercialization of medicines for indications for which there are inadequate or no therapies. All assets of the company are located in the United Kingdom.

The company has a market cap of $1.63 billion. Its shares traded at $4.85 as of Nov. 13.

Net loss for the quarter ended June 30 was $15.23 million compared to a loss of $6.68 million for the prior-year period.

American Assets Trust

American Assets Trust Inc. (NYSE:AAT) Chairman, CEO, President and 10% Owner Ernest S. Rady bought 184,994 shares during the past week at the average price of $22.75.

1685a29693e36c12736ab80507aa6cf3.png

American Assets Trust is a self-administered real estate investment trust based in the United States. The company invests in, operates and develops retail, office, residential and mixed-use properties primarily located in California, Oregon, Washington and Hawaii.

The company has a market cap of $1.60 billion. Its shares traded at $26.60 with a price-earnings ratio of 42.29 as of Nov. 13.

Net income for the third quarter of 2020 was $5.0 million compared to $12.9 million for the third quarter of 2019.

Rady bought 175,739 shares on Nov. 4 at a price of $21.64; 130,000 shares on Nov. 6 at a price of $21.49; and 54,994 shares on Nov. 11 at the average price of $25.72. Since then, the price of the stock has increased by 3.42%.

Dun & Bradstreet Holdings

Dun & Bradstreet Holdings Inc. (NYSE:DNB) CEO Anthony M. Jabbour bought 38,000 shares on Nov. 6 at a price of $26.31. The price of the stock has increased by 4.14% since then.

c651043b51b23756e57fb01de2db5827.png

Dun & Bradstreet Holdings is one of the leading providers of business decisioning data and analytics. The company provides commercial credit decisioning, which helps businesses to make informed decisions when considering extending business loans and trade credit. Also, the company offers solutions to firms looking to analyze supplier relationships and more effectively collect outstanding receivables. Other services include digital marketing, sales acceleration and risk management, among others.

The company has a market cap of $11.59 billion. Its shares traded at $27.40 as of Nov. 13.

On June 30, the company announced the pricing of its initial public offering of 78,302,272 shares of common stock at an initial public offering price of $22.00 per share.

Chief Financial Officer Bryan T. Hipsher bought 4,000 shares on Nov. 6 at a price of $26.39. Since then, the price of the stock has increased by 3.83%.

OPKO Health

OPKO Health Inc. (NASDAQ:OPK) CEO, Chairman and 10% Owner Phillip Frost bought 250,000 shares on Nov. 9 at a price of $3.18. The price of the stock has increased by 25.47% since then.

b7d233c2ab8389ceb7c0a8d2354e84f3.png

Opko Health is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a specialty active pharmaceutical ingredients manufacturer in Israel.

The company has a market cap of $2.67 billion. Its shares traded at $3.99 as of Nov. 13.

Net income for the third quarter of 2020 was $23.7 million compared with a net loss of $62.0 million for the comparable period of 2019.

Frost also bought 600,000 shares on Oct. 30 at a price of $3.45. Since then, the price of the stock has increased by 15.65%.

ViewRay

ViewRay Inc. (NASDAQ:VRAY) President and CEO Scott William Drake bought 155,000 shares on Nov. 10 at a price of $3.23. The price of the stock has increased by 20.74% since then.

93ec9d95c576aa0438f5bc72e46a229f.png

ViewRay is a radiation therapy and imaging technology company. It designs, manufactures and markets radiation therapy systems that provide real-time imaging during radiation treatment. Its product portfolio encompasses The MRIdian linac system, The MRIdian system, Monte Carlo treatment planning system, etc. The company holds license for its combination of MRI and radiation therapy technologies.

The company has a market cap of $579.15 million. Its shares traded at $3.90 as of Nov. 13.

Net loss for the third quarter of 2020 was $28.13 million compared to a loss of $20.83 million for the prior-year period.

For the complete list of stocks bought by their company CEOs, go to: CEO Buys.

Disclosure: I do not own stock in any of the companies mentioned in the article.

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.

  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by Joy Hu


User Generated Screeners


pjmason14Momentum
wigbertHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)